---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-013836"
form_type: "8-K"
ticker: "USAQ"
cik: "0000856984"
company_name: "QHSLab, Inc."
filed_at: "2026-03-31T23:59:59+00:00"
generated_at: "2026-05-15T08:18:46.748515+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# QHSLab reports fiscal 2025 net income of $457K, revenue up 26% to $2.69M

## Summary
- Revenue $2.69M (+26% YoY); net income $457,417 vs net loss $259,239 in 2024.
- Gross margin expanded to 67.3% from 63.7%; gross profit $1.81M vs $1.36M.
- Current liabilities reduced to ~$450K from ~$2.4M; cash increased to $636K from $157K.
- ISP revenue grew 74% YoY to $1.12M; immunotherapy sales up ~19%.
- Recorded ~$1.15M gain on extinguishment of convertible debt; interest expense halved to $237K.

## SEC filing metadata
- accession: 0001493152-26-013836
- form_type: 8-K
- ticker: USAQ
- cik: 0000856984
- company_name: QHSLab, Inc.
- filed_at: 2026-03-31T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856984/000149315226013836/0001493152-26-013836-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856984/000149315226013836/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-013836
- JSON: https://secwatch.observer/filing/0001493152-26-013836.json
- Plain text: https://secwatch.observer/filing/0001493152-26-013836.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.